Literature DB >> 10681524

Human vascular smooth muscle cells possess functional CCR5.

A D Schecter1, T M Calderon, A B Berman, C M McManus, J T Fallon, M Rossikhina, W Zhao, G Christ, J W Berman, M B Taubman.   

Abstract

CC chemokine receptors are important modulators of inflammation. Although CC chemokine receptors have been found predominantly on leukocytes, recent studies have suggested that vascular smooth muscle cells respond to CC chemokines. We now report that human smooth muscle cells express CCR5, a co-receptor for human immunodeficiency virus. CCR5 mRNA was detectable by RNA blot hybridization in human aortic and coronary artery smooth muscle cells. The cDNA generated by reverse transcription-polymerase chain reaction from aortic smooth muscle cells had 100% identity throughout the entire coding region with the CCR5 cloned from THP-1 cells. By immunohistochemistry, CCR5 and the CCR5 ligand, macrophage inflammatory protein-1beta (MIP-1beta), were detected in smooth muscle cells and macrophages of the atherosclerotic plaque. In smooth muscle cell culture, MIP-1beta induced a significant increase in intracellular calcium concentrations, which was blocked by an antibody to CCR5. In addition, MIP-1beta caused a calcium-dependent increase in tissue factor activity. Tissue factor is the initiator of coagulation and is thought to play a key role in arterial thrombosis. These data suggest that human arterial smooth muscle cells express functional CCR5 receptors and MIP-1beta is an agonist for these cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10681524     DOI: 10.1074/jbc.275.8.5466

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

Review 1.  Stem cell origins of intimal cells in graft arterial disease.

Authors:  Koichi Shimizu; Richard N Mitchell
Journal:  Curr Atheroscler Rep       Date:  2003-05       Impact factor: 5.113

Review 2.  The Search for Disease-Modifying Therapies in Pulmonary Hypertension.

Authors:  Chen-Shan Chen Woodcock; Stephen Y Chan
Journal:  J Cardiovasc Pharmacol Ther       Date:  2019-02-17       Impact factor: 2.457

Review 3.  Chemokine receptor CCR5: from AIDS to atherosclerosis.

Authors:  K L Jones; J J Maguire; A P Davenport
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

4.  HIV envelope gp120 activates human arterial smooth muscle cells.

Authors:  A D Schecter; A B Berman; L Yi; A Mosoian; C M McManus; J W Berman; M E Klotman; M B Taubman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

5.  Structure-function studies on non-synonymous SNPs of chemokine receptor gene implicated in cardiovascular disease: a computational approach.

Authors:  A Sai Ramesh; Rao Sethumadhavan; Padma Thiagarajan
Journal:  Protein J       Date:  2013-12       Impact factor: 2.371

6.  CCR5 as a treatment target in pulmonary arterial hypertension.

Authors:  Larissa Lipskaia; Shariq Abid; Lucie Poupel; Valérie Amsellem; Amal Houssaini; Rozenn Quarck; Elisabeth Marcos; Nathalie Mouraret; Aurélien Parpaleix; Régis Bobe; Guillaume Gary-Bobo; Mirna Saker; Jean-Luc Dubois-Randé; Mark T Gladwin; Karen A Norris; Marion Delcroix; Christophe Combadière; Serge Adnot
Journal:  Circulation       Date:  2014-07-03       Impact factor: 29.690

7.  CCR5 deletion protects against inflammation-associated mortality in dialysis patients.

Authors:  Friso L H Muntinghe; Marion Verduijn; Mike W Zuurman; Diana C Grootendorst; Juan Jesus Carrero; Abdul Rashid Qureshi; Karin Luttropp; Louise Nordfors; Bengt Lindholm; Vincent Brandenburg; Martin Schalling; Peter Stenvinkel; Elisabeth W Boeschoten; Raymond T Krediet; Gerjan Navis; Friedo W Dekker
Journal:  J Am Soc Nephrol       Date:  2009-04-23       Impact factor: 10.121

8.  Independent expression of the two paralogous CCL4 genes in monocytes and B lymphocytes.

Authors:  Jun Lu; Marek Honczarenko; Steven R Sloan
Journal:  Immunogenetics       Date:  2003-12-13       Impact factor: 2.846

Review 9.  Cannabinoid receptors in acute and chronic complications of atherosclerosis.

Authors:  F Mach; F Montecucco; S Steffens
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

10.  Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.

Authors:  Michelle Floris-Moore; Zahi A Fayad; Joan W Berman; Venkatesh Mani; Ellie E Schoenbaum; Robert S Klein; Karen B Weinshelbaum; Valentin Fuster; Andrea A Howard; Yungtai Lo; Alison D Schecter
Journal:  AIDS       Date:  2009-05-15       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.